Metformin has displayed anticancer effects towards different types of cancer cells in an in vitro cell study, with Nrf2, YAP, HIF-1α, HMGB1, TGF-β1, glycolysis and glutamine metabolism being proposed action targets at a cellular level [14,18,19,20,21,22,23]. This evidence concerns the gene HMGB1 and cancer.